NASDAQ | ETF
Under normal circumstances, the fund invests at least 80% of its net assets, plus any borrowings for investment purposes, in equity securities ofU. S. companies with very large (mega) market capitalizations at the time of purchase.
For this fund, companies with mega capitalizations are those with market capitalizations in the top 50th percentile of the S&P 500 Index at the time of purchase.
The fund is non-diversified.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| NVDA | NVIDIA Corporation | Technology | Semiconductors | 7.44% |
| AAPL | Apple Inc | Technology | Consumer Electronics | 7.31% |
| GOOGL | Alphabet Inc Class A | Communication Services | Internet Content & Information | 6.17% |
| MSFT | Microsoft Corporation | Technology | Software - Infrastructure | 5.19% |
| JPM | JPMorgan Chase & Co | Financial Services | Banks - Diversified | 4.84% |
| XOM | Exxon Mobil Corp | Energy | Oil & Gas Integrated | 4.76% |
| COST | Costco Wholesale Corp | Consumer Defensive | Discount Stores | 4.74% |
| V | Visa Inc. Class A | Financial Services | Credit Services | 4.32% |
| TSLA | Tesla Inc | Consumer Cyclical | Auto Manufacturers | 4.24% |
| MA | Mastercard Inc | Financial Services | Credit Services | 4.24% |
| UNH | UnitedHealth Group Incorporated | Healthcare | Healthcare Plans | 4.12% |
| META | Meta Platforms Inc. | Communication Services | Internet Content & Information | 4.08% |
| AVGO | Broadcom Inc | Technology | Semiconductors | 3.83% |
| LLY | Eli Lilly and Company | Healthcare | Drug Manufacturers - General | 3.81% |
| ABBV | AbbVie Inc | Healthcare | Drug Manufacturers - General | 3.77% |
| BRK-B | Berkshire Hathaway Inc | Financial Services | Insurance - Diversified | 3.74% |
| AMZN | Amazon.com Inc | Consumer Cyclical | Internet Retail | 3.72% |
| PG | Procter & Gamble Company | Consumer Defensive | Household & Personal Products | 3.63% |
| CRM | Salesforce.com Inc | Technology | Software - Application | 3.62% |
| JNJ | Johnson & Johnson | Healthcare | Drug Manufacturers - General | 3.52% |